Catalyst Wire Dossier Catalyst Wire Dossier

NEVANAC 0.1%

nepafenac · Alcon Research
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for NEVANAC 0.1%, covering 2011-09-21 to 2011-09-21. Get the full timeline:

Most recent: Clinical Trial Update: A Clinical Safety and Efficacy Comparison of NEVANAC 0.1% to Vehicle After Cataract Surgery in Diabetic Retinopathy Patients [Phase 2]

See pricing